The <scp>FDA</scp> and the <scp>COVID</scp>‐19: A political economy perspective

March, Raymond J.

doi:10.1002/soej.12494

Cited by 12 publications

(2 citation statements)

References 68 publications

(64 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Будучи крупным заказчиком услуг лоббистов в Конгрессе США, фармацевтические корпорации оплачивают не более 15% таких заказов (30 из 200 млн долл.). Вес вложений фармацевтов в общие расходы на лоббирование (чуть более 40 млн 12 [Яновский, Жаворонков, Черный, 2017], а также [March, 2021]. )…”

Section: защита потребителя от недоброкачественных лекарствunclassified

The Health Cure: Historical Experience of Old Democracy and Lessons for Russia

Yanovskiy

2023

IET

View full text Add to dashboard Cite

Contrary to widespread belief government-run Healthcare was not the first mass affordable solution for medical problems. Governmental healthcare has not caused main breakthroughs in the mortality decrease and significant increase in average life expectancy. Safeguards for private property and ironclad protection of personal rights and liberties caused modern economic growth phenomena, a rise in wealth, and unleashed scientific and technical progress. The rise in wealth and scientific progress were the principal reasons behind progress in medicine. Nowadays huge government spending and poor efficiency make unclear the overall impact of government-run healthcare on public health. The government's Famous attempts to protect drug consumers caused huge costs possibly outweighing their benefits. The foremost public concern ought to be the numerous ethical challenges of the governmental rule in Healthcare, the power usurped by healthcare officials to decide for and instead the patient his fate.

show abstract

Section: защита потребителя от недоброкачественных лекарствunclassified

The Health Cure: Historical Experience of Old Democracy and Lessons for Russia

Yanovskiy

2023

IET

View full text Add to dashboard Cite

show abstract

“…In general, the study of aggregation paradoxes and public choice outcomes has received substantial treatment. Klein [25], March [26], Sobel [27], and Tabarrok [28,29], and Leeson and Thompson [30] each consider the role of the FDA in public health outcomes. Each of these studies finds government failures stemming from the FDA's decision-making criteria, where the FDA depends heavily on non-parametric efficacy tests that are subject to aggregation paradoxes.…”

Section: Introductionmentioning

confidence: 99%

Simpson's aggregation paradox in nonparametric statistical analysis: Theory, computation, and susceptibility in public health data

Sanders

Ehrlich

Boudreau

2023

Front. Appl. Math. Stat.

View full text Add to dashboard Cite

This study establishes sufficient conditions for observing instances of Simpson's (data aggregation) Paradox under rank sum scoring (RSS), as used, e.g., in the Wilcoxon-Mann-Whitney (WMW) rank sum test. The WMW test is a primary nonparametric statistical test in FDA drug product evaluation and other prominent medical settings. Using computational nonparametric statistical methods, we also establish the relative frequency with which paradox-generating Simpson Reversals occur under RSS when an initial data sequence is pooled with its ordinal replicate. For each 2-sample, n-element per sample or 2 x n case of RSS considered, strict Reversals occurred for between 0% and 1.74% of data poolings across the whole sample space, roughly similar to that observed for 2 x 2 x 2 contingency tables and considerably less than that observed for path models. The Reversal rate conditional on observed initial sequence is highly variable. Despite a mode at 0%, this rate exceeds 20% for some initial sequences. Our empirical application identifies clusters of Simpson Reversal susceptibility for publicly-released mobile phone radiofrequency exposure data. Simpson Reversals under RSS are not simply a theoretical concern but can reverse nonparametric or parametric biostatistical results even in vitally important public health settings. Conceptually, Paradox incidence can be viewed as a robustness check on a given WMW statistical test result. When an instance of Paradox occurs, results constituting this instance are found to be data-scale dependent. Given that the rate of Reversal can vary substantially by initial sequence, the practice of calculating this rate conditional on observed initial sequence represents a potentially important robustness check upon a result.

show abstract

The political economy of theCOVID‐19 pandemic

Boettke

Powell

2021

Southern Economic Journal

View full text Add to dashboard Cite

We argue that the policy response to the COVID‐19 pandemic by all levels of government around the world is not consistent with recommendations from standard welfare economics. Thus, it is important to ask why such policies have been adopted. That opens the door to examining the political economy of the COVID‐19 pandemic. This requires examining the incentives and information that confront policymakers and voters and the institutional environments that shape their incentives and information. This lead article frames questions addressed in the remainder of the symposium.

show abstract

The FDA and the COVID‐19: A political economy perspective

Cited by 12 publications

References 68 publications

The Health Cure: Historical Experience of Old Democracy and Lessons for Russia

The Health Cure: Historical Experience of Old Democracy and Lessons for Russia

Simpson's aggregation paradox in nonparametric statistical analysis: Theory, computation, and susceptibility in public health data

The political economy of theCOVID‐19 pandemic

Contact Info

Product

Resources

About